Weinstein DA - Search Results

1

Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy.

Okechuku GO, Shoemaker LR, Dambska M, Brown LM, Mathew J, Weinstein DA. Okechuku GO, et al. Among authors: weinstein da. J Inherit Metab Dis. 2017 Sep;40(5):703-708. doi: 10.1007/s10545-017-0054-2. Epub 2017 Jun 13. J Inherit Metab Dis. 2017. PMID: 28612263

2

Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia.

Lee YM, Conlon TJ, Specht A, Coleman KE, Brown LM, Estrella AM, Dambska M, Dahlberg KR, Weinstein DA. Lee YM, et al. Among authors: weinstein da. J Inherit Metab Dis. 2018 Nov;41(6):977-984. doi: 10.1007/s10545-018-0199-7. Epub 2018 May 25. J Inherit Metab Dis. 2018. PMID: 29802554

3

Evaluation of glycogen storage disease as a cause of ketotic hypoglycemia in children.

Brown LM, Corrado MM, van der Ende RM, Derks TG, Chen MA, Siegel S, Hoyt K, Correia CE, Lumpkin C, Flanagan TB, Carreras CT, Weinstein DA. Brown LM, et al. Among authors: weinstein da. J Inherit Metab Dis. 2015 May;38(3):489-93. doi: 10.1007/s10545-014-9744-1. Epub 2014 Jul 29. J Inherit Metab Dis. 2015. PMID: 25070466

4

Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control.

Dambska M, Labrador EB, Kuo CL, Weinstein DA. Dambska M, et al. Among authors: weinstein da. Pediatr Diabetes. 2017 Aug;18(5):327-331. doi: 10.1111/pedi.12540. Epub 2017 Jun 1. Pediatr Diabetes. 2017. PMID: 28568353 Review.

5

Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.

Beegle RD, Brown LM, Weinstein DA. Beegle RD, et al. Among authors: weinstein da. JIMD Rep. 2015;18:23-32. doi: 10.1007/8904_2014_344. Epub 2014 Oct 12. JIMD Rep. 2015. PMID: 25308557 Free PMC article.

6

High Incidence of Serologic Markers of Inflammatory Bowel Disease in Asymptomatic Patients with Glycogen Storage Disease Type Ia.

Lawrence NT, Chengsupanimit T, Brown LM, Weinstein DA. Lawrence NT, et al. Among authors: weinstein da. JIMD Rep. 2015;24:123-8. doi: 10.1007/8904_2015_452. Epub 2015 Jun 21. JIMD Rep. 2015. PMID: 26093626 Free PMC article.

7

Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I.

Ross KM, Brown LM, Corrado MM, Chengsupanimit T, Curry LM, Ferrecchia IA, Porras LY, Mathew JT, Weinstein DA. Ross KM, et al. Among authors: weinstein da. JIMD Rep. 2016;26:85-90. doi: 10.1007/8904_2015_488. Epub 2015 Aug 25. JIMD Rep. 2016. PMID: 26303612 Free PMC article.

8

Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.

Ross KM, Ferrecchia IA, Dahlberg KR, Dambska M, Ryan PT, Weinstein DA. Ross KM, et al. Among authors: weinstein da. Adv Nutr. 2020 Mar 1;11(2):439-446. doi: 10.1093/advances/nmz092. Adv Nutr. 2020. PMID: 31665208 Free PMC article. Review.

9

Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control.

Bernier AV, Sentner CP, Correia CE, Theriaque DW, Shuster JJ, Smit GP, Weinstein DA. Bernier AV, et al. Among authors: weinstein da. J Inherit Metab Dis. 2008 Dec;31(6):729-32. doi: 10.1007/s10545-008-0919-5. Epub 2008 Aug 19. J Inherit Metab Dis. 2008. PMID: 18709545 Free PMC article.

10

Inflammatory Bowel Disease in Glycogen Storage Disease Type Ia.

Lawrence NT, Chengsupanimit T, Brown LM, Derks TG, Smit GP, Weinstein DA. Lawrence NT, et al. Among authors: weinstein da. J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):e52-e54. doi: 10.1097/MPG.0000000000000592. J Pediatr Gastroenterol Nutr. 2017. PMID: 25304890 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page